In just a decade of its existence, IfeanHealth, Nigeria’s leading provider for prosthetics and orthotics healthcare solutions, has, through a strategic training initiative, built technical capacity and fostered a strong professional community committed to raising the standard of prosthetic and orthotic care nationwide.
Speaking recently about the impact of the training, Ejike Anih, managing director /CEO of IfeanHealth, said the company’s commitment goes beyond innovation; it is about empowering those who empower others.
Anih said with this initiative, the company is investing in the Certified Prosthetists and Orthotists (CPOs) across Nigeria who give people back their ability to walk, live fully, and stand tall with dignity.
According to him, in partnership with Ottobock, the global leader in prosthetics technologies, IfeanHealth is deepening its commitment to excellence in patient care through a nationwide training initiative for Certified Prosthetists and Orthotists (CPOs).
Anih said that as the exclusive distributor of Ottobock components in Nigeria, IfeanHealth is focused on equipping professionals with the latest skills and knowledge to deliver world-class prosthetics solutions.
“These training sessions are hands-on, practical, and tailored to help CPOs better understand and utilise Ottobock’s industry-leading technologies,” he said.
Anih said the company’s training team has completed training programmes in Kano, Maiduguri and Sokoto, with more states scheduled in the coming months, adding that by bringing these trainings directly to regions across Nigeria, IfeanHealth is bridging the knowledge gap and promoting best practices in prosthetic care.
IfeanHealth is a US-founded health technology company specialising in prosthetics and orthotics care, with a rapidly expanding footprint across Nigeria and West Africa. Renowned for its patient-centred approach, innovative solutions and partnership with Ottobock, IfeanHealth is redefining healthcare access and quality for people with limb loss and mobility challenges.